第十一批集采7个品种霸屏!呼吸系统“药王”大跌,2个吸入剂涨逾100%,仁合益康、倍特蓄力

米内网
Sep 05

精彩内容第十一批国采正式标书有望于近日浮出水面。7个呼吸系统药物拟被纳入,石家庄四药、仁合益康、倍特药业等有多个品种在列;10个呼吸系统药物暂被集采“放过”,24亿大品种在列。米内网数据显示,近年来中国公立医疗机构终端呼吸系统化药市场承压,2024年、2025年一季度连续下滑,阿斯利康领跑市场;产品TOP20中,“药王”大跌,2个吸入剂逆势涨逾100%。超400亿市场承压,吸入剂“称王”米内网数据...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10